Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

DoD Seeks Supplier for 2018-2019 Seasonal Influenza Vaccine

by Stephanie Lizotte
February 19, 2018
Influenza Virus

Credit: Shutterstock

The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Influenza Vaccine for the 2018-2019 flu season. Approximately 3.6 million doses are included in this requirement.

The vaccines shall be in the following presentations: multi-dose vials and prefilled syringes.  The vaccine shall be FDA-approved for the following age categories: for immunizing individuals 18 years and older; for immunizing individuals 9 years and older; and for immunizing individuals 3 years and older.  Also, 10-pack prefilled syringes for immunizing 6 months to 35 months (pediatric group).

The formula for the 2018-2019 season shall be determined by the FDA’s Vaccines and Related Biological Products Advisory Committee.  Other specification data is included in the solicitation.  Successful contractor must have FDA Approval.  National Stock Numbers shall be established at time of award.

An indefinite quantity contract is proposed.  The quantity indicated is an annual estimate only.  The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate.

Further details are available via Solicitation Number: SPE2DP18R0001. The response deadline is Mar 16, 2018 3:00 pm Eastern.

Tags: InfluenzaRequest for QuotesVaccines

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC